U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
For more: [ Ссылка ]
►Subscribe: [ Ссылка ]
►Website: [ Ссылка ]
►Facebook: [ Ссылка ]
►Twitter: [ Ссылка ]
